![Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome | British Journal of Cancer Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-018-0115-9/MediaObjects/41416_2018_115_Fig3_HTML.png)
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome | British Journal of Cancer
![Serum Cancer Antigen 19-9 (CA 19-9) and total bilirubin concentrations... | Download Scientific Diagram Serum Cancer Antigen 19-9 (CA 19-9) and total bilirubin concentrations... | Download Scientific Diagram](https://www.researchgate.net/publication/51494119/figure/fig2/AS:323564575182852@1454155214782/Serum-Cancer-Antigen-19-9-CA-19-9-and-total-bilirubin-concentrations-in-a-60-year-old.png)
Serum Cancer Antigen 19-9 (CA 19-9) and total bilirubin concentrations... | Download Scientific Diagram
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. | Semantic Scholar Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/07f6e002e24412608f31a631a5d341f3ff7e3380/3-Figure1-1.png)
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. | Semantic Scholar
![CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube](https://i.ytimg.com/vi/eOWd34Q2NoM/maxresdefault.jpg)
CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube
![Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine | British Journal of Cancer Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6601263/MediaObjects/41416_2003_Article_BF6601263_Fig1_HTML.jpg)
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine | British Journal of Cancer
![Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma | Scientific Reports Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-38988-8/MediaObjects/41598_2019_38988_Fig1_HTML.png)
Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma | Scientific Reports
![Hepatitis autoinmune con elevación de CA 19-9 y normalización con tratamiento inmunosupresor: reporte de caso y revisión de la literatura Hepatitis autoinmune con elevación de CA 19-9 y normalización con tratamiento inmunosupresor: reporte de caso y revisión de la literatura](http://www.scielo.org.pe/img/revistas/rgp/v28n2/a11tab01a.jpg)
Hepatitis autoinmune con elevación de CA 19-9 y normalización con tratamiento inmunosupresor: reporte de caso y revisión de la literatura
![Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis - Airong Shen, Shengnan Xu, Yange Ma, Huanhuan Guo, Canyu Li, Chunli Yang, Shunhong Zou, 2015 Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis - Airong Shen, Shengnan Xu, Yange Ma, Huanhuan Guo, Canyu Li, Chunli Yang, Shunhong Zou, 2015](https://journals.sagepub.com/cms/10.1177/0300060515583076/asset/images/large/10.1177_0300060515583076-fig1.jpeg)
Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis - Airong Shen, Shengnan Xu, Yange Ma, Huanhuan Guo, Canyu Li, Chunli Yang, Shunhong Zou, 2015
![High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma | Anticancer Research High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/39/1/375/F4.large.jpg)
High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma | Anticancer Research
![Detección de CA-19.9 citosólico en adenomas colorrectales: Utilidad en el diagnóstico de la displasia Detección de CA-19.9 citosólico en adenomas colorrectales: Utilidad en el diagnóstico de la displasia](https://scielo.isciii.es/img/diges/v96n4/images/es_original2_tabla1.jpg)
Detección de CA-19.9 citosólico en adenomas colorrectales: Utilidad en el diagnóstico de la displasia
![Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna](https://www.scielo.cl/fbpe/img/rchcir/v65n4/tb04-01.jpg)
Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna
![PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/2-Figure1-1.png)